Dali Pharmaceutical (603963)

Dali Pharmaceutical (603963)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021

Description

Dali Pharmaceutical Co., Ltd. is a China-based company principally involved in the production and sales of Chinese and western medicine injections. The Company?s main products include Xingnaojing injections and Shenmai injections. The other products include astragalus injections and mycorrhizal injections. Through its subsidiaries, the Company is also involved in the lease of offices and factory buildings, as well as the investment of equity.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner